Mechanistically, AR inhibition upregulates PSMA expression which leads to higher uptake of PSMA-ligand drugs such as 177 Lu-PSMA-617 and increased PSMA tracer uptake on PET in patients with PCa. This evidence concerns the gene AR and posterior cortical atrophy.